All the news Showing 10 of 217 articles from: Pharmaceutical industryGet an RSS feed of these articles Show All news infohep newsEditors' picks from other sources HCV drug out of the running MedPage Today / 23 June 2014 UNITED STATES: FDA Approves AbbVie's Hepatitis C Regimen for Priority Review CDC / 19 June 2014 FDA lifts hold on Achillion's hepatitis C drug, shares jump Reuters / 11 June 2014 Merck to acquire hepatitis C drug developer Press Herald / 11 June 2014 French Transparency agency backs Gilead’s new hepatitis C drug Sovaldi EATG / The Pharma Letter / 10 June 2014 Top payer group shoots down Gilead's hep C drug Sovaldi on price FiercePharma / 22 May 2014 OLYSIO™ (simeprevir) receives marketing authorisation in the European Union for the treatment of adults with hepatitis C genotype 1 and 4 infection Reuters / 16 May 2014 For Drugs That Save Lives, a Steep Cost New York Times / 28 April 2014 Biotech’s Hard Bargain The New Yorker / 24 April 2014 AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C AbbVie press release / 23 April 2014 ← Prev1...1617181920...22Next → Other pages in this section Latest news All the news Hepatitis A Hepatitis B Hepatitis C Hepatitis D Hepatitis E Coronavirus NAFLD Treatment for hepatocellular carcinoma Transmission, epidemiology and prevention Health services, policy and advocacy Access to medicines & diagnostics Hepatitis C elimination Models of care Finance, funding & health economics National policy European policy International policy Activism and civil society Pharmaceutical industry Social issues Conference news Noticeboard Email bulletins News feeds